Tuoxin Pharmaceutical Group Co.,Ltd. (SHE:301089)

Market Cap	3.71B +2.8%
Revenue (ttm)	367.49M -11.5%
Net Income	-47.39M
EPS	-0.40
Shares Out	126.54M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	7,435,347
Average Volume	4,930,493
Open	31.95
Previous Close	32.64
Day's Range	30.56 - 32.37
52-Week Range	23.20 - 41.50
Beta	-0.85
RSI	44.57
Earnings Date	Mar 28, 2026

About SHE:301089

Tuoxin Pharmaceutical Group Co.,Ltd. engages in the research and development, production and sales of nucleoside (acid) APIs and pharmaceutical intermediates in China. It offers nucleoside (acid) products, such as pyrimidine series, purine series, and nucleotide series; nucleoside series, including citicoline sodium, ribavirin, inosine, acyclovir, azithromycin, cytosine, 5-fluorocytosine, cytidine, uridine; and other APIs and pharmaceutical intermediates covering antiviral, anti-tumor, and nervous system. The company was founded in 2001 and is ...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 2001
• Employees: 1,551
• Stock Exchange: Shenzhen Stock Exchange
• Ticker Symbol: 301089